El primer episodio estará dedicado a uno de los grandes campos de la innovación a nivel mundial, uno de los que más dudas y controversias genera y que, en tiempos de pandemia y de vacunas, está de plena actualidad. Hablaremos de las patentes biotecnológicas con la participación de Nicolás Vincent Ruiz, Global Intellectual Property Head de ESTEVE, junto a Patricia Ramos, directora Área Patentes PONS IP y Ana Herrera Arroyo, responsable de Biotecnología del Área Patentes PONS IP a la que también hemos entrevistado. Para la firma invitada, contaremos con la participación de José Antonio Gil Celedonio, director de la Oficina Española de Patentes y Marcas (OEPM).
IP newsthat
may interest you
Luis Ignacio Vicente, Strategic Advisor, and Guillermo Criado, Director of International Business Development at PONS IP, have been recognised for the second consecutive year in the prestigious international ranking IAM Strategy 300: The World’s Leading IP Strategists 2025, compiled by...
From a specialised course to a global think tank with a Spanish spirit. The third edition of the forum “Web3, AI and Quantum Computing (WAIQ): Challenges and Opportunities for Innovators, Legal Professionals and Other Curious Minds”, held this week at...
The new General-Purpose Artificial Intelligence Code of Practice marks a turning point in the effective implementation of the Artificial Intelligence Act (AI Act) in the European Union. After months of speculation about the implementation timeline and feasibility of the planned...
NEWSLETTER
All the IP News
in your e-mail
Find out all the latest information on IP to boost the development of your organisation.
Subscribe to our bimonthly newsletter

International Awards
and Recognitions
